Renalytix plc (RNLXY) stock
RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)
Close on Oct 19, 2026Market cap $375.75MP/E –Yield –
Renalytix market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Renalytix's market cap was $589.87M on Oct 19, 2026, against $22.50B a year earlier. Over the last 5 years it ranged from $217.36M to $834.78B, with a median of $30.29B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $589.87M | -1.8% |
| 2025 | Dec 31, 2025 | $600.65M | -97.2% |
| 2024 | Dec 31, 2024 | $21.78B | -4.7% |
| 2023 | Dec 29, 2023 | $22.86B | -73.9% |
| 2022 | Dec 30, 2022 | $87.53B | -87.8% |
| 2021 | Dec 31, 2021 | $717.46B | +20.8% |
| 2020 | Dec 31, 2020 | $594.16B | – |
See a number that looks wrong?